Veru Basic EPS 2010-2024 | VERU
Veru basic eps from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| Veru Annual Basic EPS | |
|---|---|
| 2024 | $-0.28 |
| 2023 | $-1.10 |
| 2022 | $-1.05 |
| 2021 | $0.10 |
| 2020 | $-0.28 |
| 2019 | $-0.19 |
| 2018 | $-0.44 |
| 2017 | $-0.25 |
| 2016 | $0.01 |
| 2015 | $0.15 |
| 2014 | $0.09 |
| 2013 | $0.51 |
| 2012 | $0.55 |
| 2011 | $0.20 |
| 2010 | $0.25 |
| 2009 | $0.25 |
| Veru Quarterly Basic EPS | |
|---|---|
| 2024-12-31 | $-0.06 |
| 2024-09-30 | $-0.06 |
| 2024-06-30 | $-0.07 |
| 2024-03-31 | $-0.07 |
| 2023-12-31 | $-0.08 |
| 2023-09-30 | $-0.06 |
| 2023-06-30 | $-0.14 |
| 2023-03-31 | $-0.42 |
| 2022-12-31 | $-0.48 |
| 2022-09-30 | $-0.51 |
| 2022-06-30 | $-0.28 |
| 2022-03-31 | $-0.18 |
| 2021-12-31 | $-0.08 |
| 2021-09-30 | $-0.08 |
| 2021-06-30 | $-0.03 |
| 2021-03-31 | $-0.04 |
| 2020-12-31 | $0.25 |
| 2020-09-30 | $-0.17 |
| 2020-06-30 | $-0.05 |
| 2020-03-31 | $-0.01 |
| 2019-12-31 | $-0.05 |
| 2019-09-30 | $-0.06 |
| 2019-06-30 | $-0.04 |
| 2019-03-31 | $-0.06 |
| 2018-12-31 | $-0.03 |
| 2018-09-30 | $-0.14 |
| 2018-06-30 | $-0.15 |
| 2018-03-31 | $-0.07 |
| 2017-12-31 | $-0.08 |
| 2017-09-30 | $-0.12 |
| 2017-06-30 | $-0.03 |
| 2017-03-31 | $-0.06 |
| 2016-12-31 | $-0.04 |
| 2016-09-30 | $-0.06 |
| 2016-06-30 | $0.02 |
| 2016-03-31 | $0.00 |
| 2015-12-31 | $0.05 |
| 2015-09-30 | $0.02 |
| 2015-06-30 | $0.04 |
| 2015-03-31 | $0.06 |
| 2014-12-31 | $0.03 |
| 2014-09-30 | $-0.01 |
| 2014-06-30 | $0.04 |
| 2014-03-31 | $0.01 |
| 2013-12-31 | $0.05 |
| 2013-09-30 | $0.24 |
| 2013-06-30 | $0.03 |
| 2013-03-31 | $0.12 |
| 2012-12-31 | $0.12 |
| 2012-09-30 | $0.29 |
| 2012-06-30 | $0.09 |
| 2012-03-31 | $0.07 |
| 2011-12-31 | $0.10 |
| 2011-09-30 | $0.17 |
| 2011-06-30 | $0.02 |
| 2011-03-31 | $0.00 |
| 2010-12-31 | $0.01 |
| 2010-09-30 | $0.21 |
| 2010-06-30 | $0.00 |
| 2010-03-31 | $0.07 |
| 2009-12-31 | $-0.03 |
| 2009-09-30 | $0.09 |
| 2009-06-30 | $0.02 |
| 2009-03-31 | $0.08 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $0.077B | $0.017B |
| Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL. | |||